Global Embolotherapy Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Embolotherapy market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Embolotherapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Embolotherapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Embolotherapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian and Stryker, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Embolotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolotherapy.

The Embolotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Embolotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Embolotherapy Segment by Company

Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology

Embolotherapy Segment by Type

Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others

Embolotherapy Segment by Application

Cancer
Peripheral Aascular Disease
Nerve System Disease
Others

Embolotherapy Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Embolotherapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Embolotherapy Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Embolotherapy Market Size by Region (2020-2031)
1.4.1 Global Embolotherapy Market Size by Region (2020-2025)
1.4.2 Global Embolotherapy Market Size by Region (2026-2031)
1.5 Key Regions Embolotherapy Market Size (2020-2031)
1.5.1 North America Embolotherapy Market Size Growth Rate (2020-2031)
1.5.2 Europe Embolotherapy Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Embolotherapy Market Size Growth Rate (2020-2031)
1.5.4 South America Embolotherapy Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Embolotherapy Market Size Growth Rate (2020-2031)
2 Embolotherapy Market by Type
2.1 Type Introduction
2.1.1 Microspheres for Embolization
2.1.2 Embolism Particles
2.1.3 Embolic coils
2.1.4 Liquid Embolic Agent
2.1.5 Auxiliary Embolization Material
2.1.6 Others
2.2 Global Embolotherapy Market Size by Type
2.2.1 Global Embolotherapy Market Size Overview by Type (2020-2031)
2.2.2 Global Embolotherapy Historic Market Size Review by Type (2020-2025)
2.2.3 Global Embolotherapy Market Size Forecasted by Type (2026-2031)
2.3 Global Embolotherapy Market Size by Regions
2.3.1 North America Embolotherapy Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Embolotherapy Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Embolotherapy Market Size Breakdown by Type (2020-2025)
2.3.4 South America Embolotherapy Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Embolotherapy Market Size Breakdown by Type (2020-2025)
3 Embolotherapy Market by Application
3.1 Type Introduction
3.1.1 Cancer
3.1.2 Peripheral Aascular Disease
3.1.3 Nerve System Disease
3.1.4 Others
3.2 Global Embolotherapy Market Size by Application
3.2.1 Global Embolotherapy Market Size Overview by Application (2020-2031)
3.2.2 Global Embolotherapy Historic Market Size Review by Application (2020-2025)
3.2.3 Global Embolotherapy Market Size Forecasted by Application (2026-2031)
3.3 Global Embolotherapy Market Size by Regions
3.3.1 North America Embolotherapy Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Embolotherapy Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Embolotherapy Market Size Breakdown by Application (2020-2025)
3.3.4 South America Embolotherapy Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Embolotherapy Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics
4.1 Embolotherapy Industry Trends
4.2 Embolotherapy Industry Drivers
4.3 Embolotherapy Industry Opportunities and Challenges
4.4 Embolotherapy Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Embolotherapy Revenue (2020-2025)
5.2 Global Embolotherapy Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Embolotherapy Key Company Headquarters & Area Served
5.4 Global Embolotherapy Company, Product Type & Application
5.5 Global Embolotherapy Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Embolotherapy Market CR5 and HHI
5.6.2 Global Top 5 and 10 Embolotherapy Players Market Share by Revenue in 2024
5.6.3 2024 Embolotherapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Medtronic
6.1.1 Medtronic Comapny Information
6.1.2 Medtronic Business Overview
6.1.3 Medtronic Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Medtronic Embolotherapy Product Portfolio
6.1.5 Medtronic Recent Developments
6.2 Boston Scientific
6.2.1 Boston Scientific Comapny Information
6.2.2 Boston Scientific Business Overview
6.2.3 Boston Scientific Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Boston Scientific Embolotherapy Product Portfolio
6.2.5 Boston Scientific Recent Developments
6.3 Terumo
6.3.1 Terumo Comapny Information
6.3.2 Terumo Business Overview
6.3.3 Terumo Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Terumo Embolotherapy Product Portfolio
6.3.5 Terumo Recent Developments
6.4 Penumbra, Inc.
6.4.1 Penumbra, Inc. Comapny Information
6.4.2 Penumbra, Inc. Business Overview
6.4.3 Penumbra, Inc. Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Penumbra, Inc. Embolotherapy Product Portfolio
6.4.5 Penumbra, Inc. Recent Developments
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Comapny Information
6.5.2 Johnson & Johnson Business Overview
6.5.3 Johnson & Johnson Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Embolotherapy Product Portfolio
6.5.5 Johnson & Johnson Recent Developments
6.6 Sirtex
6.6.1 Sirtex Comapny Information
6.6.2 Sirtex Business Overview
6.6.3 Sirtex Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Sirtex Embolotherapy Product Portfolio
6.6.5 Sirtex Recent Developments
6.7 Merit Medical
6.7.1 Merit Medical Comapny Information
6.7.2 Merit Medical Business Overview
6.7.3 Merit Medical Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Merit Medical Embolotherapy Product Portfolio
6.7.5 Merit Medical Recent Developments
6.8 Varian
6.8.1 Varian Comapny Information
6.8.2 Varian Business Overview
6.8.3 Varian Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 Varian Embolotherapy Product Portfolio
6.8.5 Varian Recent Developments
6.9 Stryker
6.9.1 Stryker Comapny Information
6.9.2 Stryker Business Overview
6.9.3 Stryker Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.9.4 Stryker Embolotherapy Product Portfolio
6.9.5 Stryker Recent Developments
6.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
6.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Comapny Information
6.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
6.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio
6.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments
6.11 Cook Medical
6.11.1 Cook Medical Comapny Information
6.11.2 Cook Medical Business Overview
6.11.3 Cook Medical Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.11.4 Cook Medical Embolotherapy Product Portfolio
6.11.5 Cook Medical Recent Developments
6.12 Kaneka
6.12.1 Kaneka Comapny Information
6.12.2 Kaneka Business Overview
6.12.3 Kaneka Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.12.4 Kaneka Embolotherapy Product Portfolio
6.12.5 Kaneka Recent Developments
6.13 Meril Life Sciences
6.13.1 Meril Life Sciences Comapny Information
6.13.2 Meril Life Sciences Business Overview
6.13.3 Meril Life Sciences Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.13.4 Meril Life Sciences Embolotherapy Product Portfolio
6.13.5 Meril Life Sciences Recent Developments
6.14 Peijia Medical Limited
6.14.1 Peijia Medical Limited Comapny Information
6.14.2 Peijia Medical Limited Business Overview
6.14.3 Peijia Medical Limited Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.14.4 Peijia Medical Limited Embolotherapy Product Portfolio
6.14.5 Peijia Medical Limited Recent Developments
6.15 Wallaby Medical
6.15.1 Wallaby Medical Comapny Information
6.15.2 Wallaby Medical Business Overview
6.15.3 Wallaby Medical Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.15.4 Wallaby Medical Embolotherapy Product Portfolio
6.15.5 Wallaby Medical Recent Developments
6.16 MicroPort Scientific Corporation
6.16.1 MicroPort Scientific Corporation Comapny Information
6.16.2 MicroPort Scientific Corporation Business Overview
6.16.3 MicroPort Scientific Corporation Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.16.4 MicroPort Scientific Corporation Embolotherapy Product Portfolio
6.16.5 MicroPort Scientific Corporation Recent Developments
6.17 Shandong Visee Medical Devices Co.,Ltd
6.17.1 Shandong Visee Medical Devices Co.,Ltd Comapny Information
6.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview
6.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.17.4 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product Portfolio
6.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Developments
6.18 Beijing Taijie Weiye Technology
6.18.1 Beijing Taijie Weiye Technology Comapny Information
6.18.2 Beijing Taijie Weiye Technology Business Overview
6.18.3 Beijing Taijie Weiye Technology Embolotherapy Revenue, Global Share and Gross Margin (2020-2025)
6.18.4 Beijing Taijie Weiye Technology Embolotherapy Product Portfolio
6.18.5 Beijing Taijie Weiye Technology Recent Developments
7 North America
7.1 North America Embolotherapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Embolotherapy Market Size by Country (2020-2025)
7.3 North America Embolotherapy Market Size Forecast by Country (2026-2031)
8 Europe
8.1 Europe Embolotherapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Embolotherapy Market Size by Country (2020-2025)
8.3 Europe Embolotherapy Market Size Forecast by Country (2026-2031)
9 Asia-Pacific
9.1 Asia-Pacific Embolotherapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Embolotherapy Market Size by Country (2020-2025)
9.3 Asia-Pacific Embolotherapy Market Size Forecast by Country (2026-2031)
10 South America
10.1 South America Embolotherapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Embolotherapy Market Size by Country (2020-2025)
10.3 South America Embolotherapy Market Size Forecast by Country (2026-2031)
11 Middle East & Africa
11.1 Middle East & Africa Embolotherapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Embolotherapy Market Size by Country (2020-2025)
11.3 Middle East & Africa Embolotherapy Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings